Low serum uric acid levels increase the risk of all-cause death and cardiovascular death in hemodialysis patients.
CONCLUSION: A lower SUA level in HD patients was associated with a higher risk of all-cause mortality and CV mortality. Moreover, higher SUA concentrations may be cardioprotective in HD patients. PMID: 32223483 [PubMed - in process]
CONCLUSIONS: The HRQOL of hemodialysis patients with CKD-FS remains poor, interacting with important functions such as sleep, vitality, cognition, and sexual function. PMID: 32468308 [PubMed - in process]
Conclusions: Serum sST2 is a novel biomarker associated with adverse clinical outcomes in MHD patients. It was significant for both all-cause and cardiovascular mortality in MHD patients and may provide better prognostic value in short-term prognosis than the classic biomarker NT-proBNP. PMID: 32460670 [PubMed - in process]
Abstract BACKGROUND: Randomized clinical trials have failed to show benefit from increasing intensity of renal replacement therapy (RRT), but continue to be frequently utilized. In addition, intensive RRT is associated with an increase in adverse events potentially secondary to small solute losses, such as phosphate. We hypothesized that, compared to less intensive RRT, intensive RRT would lead to longer duration of mechanical ventilation. RESEARCH QUESTION: Does more-intensive renal replacement therapy in critically ill patients with AKI increase time to extubation from mechanical ventilation when compared w...
CONCLUSION: Vascular access-related nerve compression is an uncommon cause for pain, sensory and motor deficits after vascular access surgery. Surgical nerve release and access revision have good clinical outcome with relief of symptoms and maintenance of the access site in the majority of patients. PMID: 32436420 [PubMed - as supplied by publisher]
Conclusions: Central venous obstruction–induced IH is likely underrecognized by clinicians and mimics idiopathic IH. Hemodialysis patients with IH should be screened with computed tomography venography of the chest. Optimal treatment is with vascular intervention or a CSF diversion procedure and can help prevent vision loss from papilledema or nervous system damage. Medical management may be appropriate in mild cases or as a bridge to definitive interventional treatment. Increased awareness among clinicians has potential to facilitate the timely diagnosis of this treatable condition with potential for good neurolog...
This study is aimed to assess the significance of elevated sIL-2R levels in MHD patients.Methods: A total of 382 MHD patients were followed-up from September 2016 to December 2019. Patients were divided into two groups: high sIL-2R, with sIL-2R levels ≥2-fold of the upper limit of normal (710 U/ml); and low sIL-2R, with sIL-2R levels
Condition: End Stage Renal Disease Intervention: Procedure: observational study Sponsor: Institute of Liver and Biliary Sciences, India Completed
CONCLUSION: Findings suggest that using BRT as a non-pharmacological intervention may effectively enhance the ADLs of HD patients. PMID: 32379668 [PubMed - as supplied by publisher]
CONCLUSION: Two COVID-19 patients on maintenance hemodialysis discharged after a month of hospitalization. The removal of cytokines through blood purification technology may be beneficial for the recovery of COVID-19 patients. PMID: 32360479 [PubMed - as supplied by publisher]
In conclusion, the majority would recommend an AVF as the mode of vascular access for HD. The most common barrier to having an AVF was patient's refusal to undergo AVF creation because of their concern about the surgical procedure. A systematic evaluation of the process that precedes the creation of AVF may allow for better utilization. PMID: 32338112 [PubMed - in process]